Target intelligence / Profile preview

Intestinal epithelial mucosa

Molecular classification
Tissue, Anatomical structure
01

Overview

The intestinal epithelial mucosa is the innermost layer of the gastrointestinal tract, serving as a critical interface between the external environment of the lumen and the internal systemic circulation (StatPearls, 2023). It is composed of a single layer of specialized epithelial cells—including enterocytes, goblet cells, and enteroendocrine cells—supported by the lamina propria and the muscularis mucosae (NIH, 2022). Its primary biological functions include the selective absorption of nutrients and water while maintaining a robust physical and immunological barrier against pathogens and toxins through tight junction proteins and mucus production. Dysfunction of this mucosal barrier or dysregulation of the associated mucosal immune system is a central feature in the pathogenesis of Inflammatory Bowel Disease (IBD), Celiac disease, and various enteric infections (Nature Reviews Gastroenterology & Hepatology, 2021). While many therapeutic agents are designed to act upon specific molecular targets within this tissue, such as TNF-alpha or integrins, the mucosa itself is considered a complex anatomical site of action rather than a discrete molecular target.

Other names
Intestinal mucosaGut mucosaIntestinal liningEnteric mucosaGastrointestinal mucosa
02

Mechanism of action

Drugs targeting the intestinal mucosa typically work by inhibiting pro-inflammatory cytokines (e.g., TNF-alpha), blocking the trafficking of leukocytes into the mucosal tissue (e.g., alpha-4 beta-7 integrin antagonism), or providing local anti-inflammatory effects to promote mucosal healing and restore barrier integrity (PubMed, 2022).

03

Biological functions

Nutrient absorptionBarrier functionImmune surveillanceMucus secretionWater and electrolyte transport (StatPearls, 2023)
04

Disease associations

Inflammatory bowel disease (Crohn's disease and Ulcerative colitis)Celiac diseaseIrritable bowel syndrome (IBS)Leaky gut syndrome (Increased intestinal permeability)Enteric infections
05

Safety considerations

Mucosal atrophyIncreased risk of opportunistic infectionsSystemic absorption of locally intended agentsImpaired nutrient absorptionPotential for malignancy with chronic immunosuppression
06

Interacting drugs

Mesalamine

5 more in the full profile.

07

Biomarkers

Fecal calprotectin (StatPearls, 2023)Fecal lactoferrin (NIH, 2022)C-reactive protein (CRP)Endoscopic mucosal healing score (Mayo Clinic Score)Zonulin (marker of intestinal permeability)

Beyond the preview

Go deeper on Intestinal epithelial mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call